Lv2
140 积分 2025-05-06 加入
Targeting cancer with small molecule pan-KRAS degraders
12天前
已完结
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
15天前
已完结
Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer
16天前
已完结
Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition
16天前
已完结
Targeting KRASG12C Mutation: Development of Effective Strategies to Overcome Drug Resistance and Limited Efficacy
16天前
已完结
Navigating the complexities of pancreatic ductal adenocarcinoma: A review on therapeutic models and RAS inhibitors
17天前
已完结
Recent advances in therapeutic targeting of the KRAS pathway in cancer
17天前
已完结
Breakthrough in RAS targeting with pan-RAS(ON) inhibitors RMC-7977 and RMC-6236
23天前
已完结
Differential Response and Resistance to KRAS‐Targeted Therapy
23天前
已完结
皖公网安备34019202002308
